Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 9—September 2003
Research

Epidemic and Nonepidemic Multidrug-Resistant Enterococcus faecium

Helen L. Leavis*†, Rob J.L. Willems†, Janetta Top†, Emile Spalburg†, Ellen M. Mascini*, Ad C. Fluit*, Andy Hoepelman*, Albert J. de Neeling†, and Marc J.M. Bonten*Comments to Author 
Author affiliations: *University Medical Center Utrecht, Utrecht, the Netherlands; †National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands

Main Article

Table 1

Description of studied Enterococcus faecium isolates

Origin
Country
n
Vancomycin-resistant E. faecium
Epidemic
United Kingdom
1
Netherlands
4
United States
11
Clinical infections
Austria
1
United Kingdom
7
Israel
2
Italy
1
Netherlands
8
United States
1
Clinical surveillance
Germany
1
France
4
United Kingdom
1
Israel
1
Italy
1
Netherlands
27
Slovenia
1
Community surveillance
United Kingdom
1
Netherlands
35
Vancomycin-susceptible E. faecium
Clinical infections
Austria
6
Belgium
1
Switzerland
3
Germany
14
Spain
8
France
8
United Kingdom
1
Greece
1
Italy
16
Poland
5
Portugal
5
Turkey
5
Clinical surveillance
Netherlands
5
Community surveillance Netherlands 14

Main Article

Page created: December 30, 2010
Page updated: December 30, 2010
Page reviewed: December 30, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external